The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Do CRISPR Germline Ethics Statements Cut It?
Abstract
The extraordinary wave of genomic-engineering innovation, driven by CRISPR-Cas9, has sparked worldwide scientific and ethical uncertainty. Great concern has arisen across the globe about whether heritable genome editing should be permissible in humans-that is, whether it is morally acceptable to modify genomic material such that the "edit" is transferable to future generations. Here I examine 61 ethics statements released by the international community within the past 3 years about this controversial issue and consider the statements' overarching positions and limitations. Despite their inability to fully address all important considerations, many of the statements may advance debate and national and international law and public policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ethical (moral) and safety concerns about certain areas of CRISPR applications, such as germline editing, are apparent around the world6.”
From CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool (2019) · cites this paper as [6]
In the citing paper
“Recently, professional scientific and medical societies, industry organizations, and CRISPR pioneers together have released greater than 60 statements and reports about whether such editing in humans is morally permissible6.”
From CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool (2019) · cites this paper as [6]
In the citing paper
“Current positions across the globe vary widely—from outright banning of the research to illegalizing its federal funding only (while still allowing private funding for research and the research itself) to authorizing federal monies for experimentation4,6,87,88.”
From CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool (2019) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Lv, J., Xie, X., Chen, Y., Li, Y., et al. (2015) · Protein & Cell · doi:10.1007/s13238-015-0153-5 · Cited by 1,135
Correction of a pathogenic gene mutation in human embryos
Ma, H., Marti-Gutierrez, N., Park, S.-W., Wu, J., Lee, Y., Suzuki, K., Koski, A., Ji, D., Hayama, T., Ahmed, R., et al. (2017) · Nature · doi:10.1038/nature23305 · Cited by 992 · cited 1×
“groups in China and were followed by a major study from Shoukrat Mitalipov and colleagues in Nature in August 2017, which reported the successful correction of a defective gene in human embryos.(9)”
BackgroundA prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733
Ormond, K. E., Mortlock, D. P., Scholes, D. T., Bombard, Y., Brody, L. C., Faucett, W. A., Garrison, N. A., Hercher, L., Isasi, R., Middleton, A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.012 · Cited by 252
Research works printed but not linked: 12
- National Academies of Sciences Engineering and Medicine. Human genome editing: science, ethics, and governance. Washington, DC: The National Academies Press (U.S.). 2017.
- 10.1007/978-1-4939-2727-2_15 · DOI · Paper page
- Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee, Board on Health Sciences Policy, Institute of Medicine; LenziRN, AltevogtBM, GostinLO, editors. Oversight and review of clinical gene transfer protocols: assessing the role of the Recombinant DNA Advisory Committee. Washington, DC: National Academies Press. 2014.
- 10.1089/crispr.2018.29007.fyu · DOI
- 10.1038/nature23305 · DOI · Paper page
- 10.1007/s10815-016-0710-8 · DOI · Paper page
- 10.1038/s41431-017-0076-0 · DOI
- 10.1038/s41431-017-0077-z · DOI
- 10.1007/s11248-017-0028-z · doi:10.1007/s11248-017-0028-z
- 10.1038/s41431-017-0024-z · DOI
- 10.1038/mt.2015.118 · DOI · Paper page
- 10.1056/NEJMp1710370 · DOI · Paper page
Cited by
CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
Brokowski, C., & Adli, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.044 · Cited by 320
Self-citationSharma, K. K., Palakolanu, S. R., Bhattacharya, J., Shankhapal, A. R., & Bhatnagar-Mathur, P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.999207 · Cited by 24
Initial heritable genome editing: mapping a responsible pathway from basic research to the clinic
Ranisch, R., Trettenbach, K., & Arnason, G. (2023) · Medicine, Health Care and Philosophy · doi:10.1007/s11019-022-10115-x · Cited by 19
Metadata
- Authors
- Brokowski, C.
- Affiliations
- Department of Emergency Medicine, Yale School of Medicine, New Haven, Connecticut.
- Venue
- The CRISPR Journal
- Publisher
- SAGE Publications
- Published
- 2018-04
- Volume
- 1
- Issue
- 2
- Pages
- 115-125
- ISSN
- 2573-1599
- 2573-1602
- PMC
- PMC6694771
- Cited by
- 96
- References
- 4
- Language
- en
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do CRISPR Germline Ethics Statements Cut It? https://app.cochat.ai/papers/10.1089/crispr.2017.0024
- The paper
- Brokowski, C. (2018). Do CRISPR Germline Ethics Statements Cut It? The CRISPR Journal. https://doi.org/10.1089/crispr.2017.0024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.